Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,421) with videos related to
Page
of 143
Sort By:
Plos One
|
September 28, 2017
Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: II. Biological consequences of exposure
Linnea M Thomas, Zachary G Jorgenson, Mark E Brigham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Kathleen N Moore, Lainie P Martin, David M O'Malley, et al.
Gynecologic Oncology
|
December 1, 2015
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study
Lisa M Landrum, William E Brady, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study
Charles Kunos, Wei Deng, Dawn Dawson, et al.
Marine Environmental Research
|
November 1, 2019
Oxidative stress, lysosomal damage and dysfunctional autophagy in molluscan hepatopancreas (digestive gland) induced by chemical contaminants
J P Shaw, M N Moore, J W Readman, et al.
Clinical Radiology
|
January 20, 2021
Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)
F Moloney, R G Kavanagh, N J Ronan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2021
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Niharika B Mettu, Susanna V Ulahannan, Johanna C Bendell, et al.
Radiography (London, England : 1995)
|
October 8, 2018
A phantom study of the performance of model-based iterative reconstruction in low-dose chest and abdominal CT: When are benefits maximized?
F Moloney, M Twomey, K James, et al.
Marine Environmental Research
|
May 30, 2006
A biological effects monitoring survey of Cardigan Bay using flatfish histopathology, cellular biomarkers and sediment bioassays: findings of the Prince Madog Prize 2003
Brett P Lyons, Grant D Stentiford, John Bignell, et al.
Physical Review Letters
|
April 7, 2010
Multiphoton photoemission from a copper cathode illuminated by ultrashort laser pulses in an RF photoinjector
P Musumeci, L Cultrera, M Ferrario, et al.
Page
of 143
Search research articles
Search
Showing results (1101-1110 of 1,421) with videos related to
Sort By:
Page
of 143
Plos One
|
September 28, 2017
Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: II. Biological consequences of exposure
Linnea M Thomas, Zachary G Jorgenson, Mark E Brigham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Kathleen N Moore, Lainie P Martin, David M O'Malley, et al.
Gynecologic Oncology
|
December 1, 2015
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study
Lisa M Landrum, William E Brady, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study
Charles Kunos, Wei Deng, Dawn Dawson, et al.
Marine Environmental Research
|
November 1, 2019
Oxidative stress, lysosomal damage and dysfunctional autophagy in molluscan hepatopancreas (digestive gland) induced by chemical contaminants
J P Shaw, M N Moore, J W Readman, et al.
Clinical Radiology
|
January 20, 2021
Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)
F Moloney, R G Kavanagh, N J Ronan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2021
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors
Niharika B Mettu, Susanna V Ulahannan, Johanna C Bendell, et al.
Radiography (London, England : 1995)
|
October 8, 2018
A phantom study of the performance of model-based iterative reconstruction in low-dose chest and abdominal CT: When are benefits maximized?
F Moloney, M Twomey, K James, et al.
Marine Environmental Research
|
May 30, 2006
A biological effects monitoring survey of Cardigan Bay using flatfish histopathology, cellular biomarkers and sediment bioassays: findings of the Prince Madog Prize 2003
Brett P Lyons, Grant D Stentiford, John Bignell, et al.
Physical Review Letters
|
April 7, 2010
Multiphoton photoemission from a copper cathode illuminated by ultrashort laser pulses in an RF photoinjector
P Musumeci, L Cultrera, M Ferrario, et al.
Page
of 143